Products
VPL unleashes canine pheromone spray
February 1st 2004Veterinary Products Laboratories (VPL) introduces the newest addition to its canine behavior modification line, D.A.P. (Dog Appeasing Pheromone) Spray. Owners seeking ways to calm their dogs during travel can look to this spray version of the anti-anxiety pheromone, the company says.
SNAP Giardia test gives results in eight minutes
February 1st 2004IDEXX Laboratories, Inc. introduces the SNAP? ELISA test to screen dogs and cats for Giardia infection. This test, the first pet-side test to identify soluble Giardia antigen, provides veterinarians with an accurate diagnosis in eight minutes.
ACell Vet unveils powder for injection as ligament, tendon treatment
January 1st 2004ACell Vet, Inc. releases ACell Vet Powder for injection as a treatment for ligament and tendon injuries in equine patients. The release is based on results from a study that examined the effect of treatment using ACell Vet Powder, suspended in sterile saline, for injuries in suspensory ligaments and superficial digital flexor tendons.
Fort Dodge Animal Health launches combo vaccine targeting WNV and related mosquito-borne diseases
January 1st 2004Fort Dodge Animal Health introduces West Nile combination vaccines to protect horses against West Nile Virus (WNV), and all strains of encephalomyelitis. The U.S. Department of Agriculture recently approved the line of West Nile-Innovator/Encephalomyelitis combination vaccines.
Web-based tool aids in practice performance evaluation
January 1st 2004IDEXX, supplier of Cornerstone practice management software, is offering a new Web-based consultation option to help evaluate practice performance. The IDEXX team will host several live Internet consultations designed in conjunction with their Practice Profile product to help veterinarians chart practice growth, discover opportunities for increased sales, monitor client compliance and compare fees, protocols and revenue against regional and national averages.
New therapy approved for control of canine atopic dermatitis
January 1st 2004Veterinarians now have a safe and effective non-steroidal option for long-term control of canine atopic dermatitis. Atopica, which contains the active ingredient cyclosporine A (CsA), has been approved by the U.S. Food and Drug Administration (FDA) for Novartis Animal Health.